Bio-Gate (BIG1.DE) Stock Price

Bio-Gate Price

CLOSED
2.88EUR-0.03 (-0.87 %)
Market closed

Revenue has compounded at 7.9% per year over the past 9 years to 7.40 M EUR. Bio-Gate's net margin stands at -15.7%, down from -8.7% several years earlier. Analysts set a median price target of 3.06 EUR, implying 6.4% above the current price. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 13% above its 52-week low.

Bio-Gate stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bio-Gate over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bio-Gate stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bio-Gate's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bio-Gate Stock Price History
DateBio-Gate Price
8/4/20262.88 EUR
8/3/20262.90 EUR
7/31/20263.28 EUR
7/30/20263.35 EUR
7/29/20263.30 EUR
7/28/20263.15 EUR
7/27/20263.25 EUR
7/24/20262.90 EUR
7/23/20263.00 EUR
7/22/20263.00 EUR
7/21/20262.87 EUR
7/20/20263.00 EUR
7/17/20263.00 EUR
7/15/20263.33 EUR
7/14/20263.33 EUR
7/13/20263.43 EUR
7/10/20263.08 EUR
7/9/20263.17 EUR
7/8/20263.00 EUR
7/7/20263.00 EUR
7/6/20263.00 EUR
7/3/20262.78 EUR
7/2/20263.05 EUR
7/1/20262.98 EUR
6/30/20263.08 EUR
6/29/20263.08 EUR
6/26/20262.95 EUR
6/25/20263.13 EUR
6/24/20263.22 EUR
6/23/20263.13 EUR
6/22/20262.98 EUR
6/19/20263.15 EUR
6/18/20263.20 EUR
6/17/20263.00 EUR
6/16/20263.30 EUR
6/15/20263.15 EUR
6/12/20263.10 EUR
6/11/20263.38 EUR
6/10/20263.38 EUR
6/9/20263.38 EUR
6/8/20263.25 EUR
6/5/20263.38 EUR
6/4/20263.35 EUR
6/3/20263.33 EUR
6/2/20263.47 EUR
6/1/20263.33 EUR
5/29/20263.25 EUR
5/28/20263.30 EUR
5/27/20263.27 EUR
5/26/20263.08 EUR
5/25/20263.45 EUR
5/22/20263.73 EUR
5/21/20263.57 EUR
5/20/20263.63 EUR
5/19/20263.50 EUR
5/18/20263.95 EUR
5/15/20263.98 EUR
5/14/20264.07 EUR
5/13/20263.87 EUR
5/12/20263.60 EUR
5/11/20263.80 EUR
5/8/20263.85 EUR
5/7/20263.77 EUR
5/6/20263.73 EUR
5/5/20263.85 EUR
5/4/20263.45 EUR
4/30/20263.55 EUR
4/29/20263.30 EUR
4/28/20263.17 EUR
4/27/20262.80 EUR
4/24/20262.90 EUR
4/23/20263.10 EUR
4/22/20263.08 EUR
4/21/20263.10 EUR
4/20/20262.90 EUR
4/17/20263.08 EUR
4/16/20262.95 EUR
4/15/20262.92 EUR
4/14/20262.85 EUR
4/13/20263.22 EUR
4/10/20263.22 EUR
4/9/20263.22 EUR
4/8/20263.22 EUR
4/7/20263.38 EUR
4/2/20263.20 EUR
4/1/20263.20 EUR
3/31/20263.20 EUR
3/30/20263.03 EUR
3/27/20263.03 EUR
3/26/20263.03 EUR
3/25/20263.05 EUR
3/24/20262.82 EUR
3/23/20262.73 EUR
3/20/20262.78 EUR
3/19/20262.78 EUR
3/18/20262.78 EUR
3/17/20262.78 EUR
3/16/20262.78 EUR
3/13/20262.75 EUR
3/12/20262.75 EUR
3/11/20262.70 EUR
3/10/20262.55 EUR
3/9/20262.75 EUR
3/6/20262.75 EUR
3/5/20262.98 EUR
3/4/20262.98 EUR
3/3/20263.17 EUR
3/2/20263.30 EUR
2/27/20262.80 EUR
2/26/20262.80 EUR
2/25/20262.85 EUR
2/24/20262.78 EUR
2/23/20262.78 EUR
2/20/20262.82 EUR
2/19/20262.80 EUR
2/18/20262.90 EUR
2/17/20262.90 EUR
2/16/20262.95 EUR
2/13/20262.87 EUR
2/12/20263.03 EUR
2/11/20262.87 EUR
2/10/20262.87 EUR
2/9/20263.17 EUR
2/6/20263.25 EUR
2/5/20263.55 EUR
2/4/20262.80 EUR
2/3/20263.98 EUR
2/2/20263.98 EUR
1/30/20263.85 EUR
1/29/20263.85 EUR
1/28/20263.80 EUR
1/27/20263.98 EUR
1/26/20263.98 EUR
1/23/20263.93 EUR
1/22/20263.93 EUR
1/21/20263.98 EUR
1/20/20263.90 EUR
1/19/20264.00 EUR
1/16/20264.00 EUR
1/15/20264.05 EUR
1/14/20264.00 EUR
1/13/20264.10 EUR
1/12/20264.10 EUR
1/9/20264.20 EUR
1/8/20263.85 EUR
1/7/20264.20 EUR
1/6/20264.15 EUR
1/5/20264.10 EUR
1/2/20263.90 EUR
12/30/20254.07 EUR
12/29/20254.15 EUR
12/23/20254.07 EUR
12/22/20254.07 EUR
12/19/20254.10 EUR
12/18/20254.12 EUR
12/17/20254.12 EUR
12/16/20254.12 EUR
12/15/20254.10 EUR
12/12/20254.10 EUR
12/11/20254.15 EUR
12/10/20254.25 EUR
12/9/20254.70 EUR
12/8/20254.70 EUR
12/5/20254.70 EUR
12/4/20254.70 EUR
12/3/20254.68 EUR
12/2/20254.68 EUR
12/1/20254.77 EUR
11/28/20254.77 EUR
11/27/20254.47 EUR
11/26/20254.42 EUR
11/25/20254.42 EUR
11/24/20254.38 EUR
11/21/20254.25 EUR
11/20/20254.25 EUR
11/19/20254.05 EUR
11/18/20254.20 EUR
11/17/20254.20 EUR
11/14/20253.90 EUR
11/13/20254.00 EUR
11/12/20254.00 EUR
11/11/20253.85 EUR
11/10/20253.85 EUR
11/7/20253.85 EUR
11/6/20253.85 EUR
11/5/20254.00 EUR
11/4/20254.00 EUR
11/3/20254.00 EUR
10/31/20253.90 EUR
10/30/20254.15 EUR
10/29/20254.15 EUR
10/28/20254.07 EUR
10/27/20254.15 EUR
10/24/20254.15 EUR
10/23/20254.15 EUR
10/22/20254.28 EUR
10/21/20254.15 EUR
10/20/20254.15 EUR
10/17/20254.15 EUR
10/16/20254.15 EUR
10/15/20254.20 EUR
10/14/20253.87 EUR
10/13/20253.95 EUR
10/10/20254.10 EUR
10/9/20254.10 EUR
10/8/20254.25 EUR
10/7/20254.25 EUR
10/6/20254.65 EUR
10/3/20254.65 EUR
10/2/20254.65 EUR
10/1/20254.50 EUR
9/30/20254.80 EUR
9/29/20254.80 EUR
9/26/20254.82 EUR
9/25/20254.82 EUR
9/24/20254.80 EUR
9/23/20254.65 EUR
9/22/20254.80 EUR
9/19/20254.80 EUR
9/18/20254.90 EUR
9/17/20254.90 EUR
9/16/20254.65 EUR
9/15/20254.65 EUR
9/12/20254.65 EUR
9/11/20254.65 EUR
9/10/20254.65 EUR
9/9/20254.50 EUR
9/8/20254.50 EUR
9/5/20254.50 EUR
9/4/20254.50 EUR
9/3/20254.55 EUR
9/2/20254.50 EUR
9/1/20254.60 EUR
8/29/20254.60 EUR
8/28/20254.70 EUR
8/27/20254.70 EUR
8/26/20254.70 EUR
8/25/20254.70 EUR
8/22/20254.90 EUR
8/21/20254.90 EUR
8/20/20254.80 EUR
8/19/20254.80 EUR
8/18/20254.72 EUR
8/15/20254.77 EUR
8/14/20254.63 EUR
8/13/20254.63 EUR
8/12/20254.60 EUR
8/11/20254.60 EUR
8/8/20254.60 EUR
Access this data via the Eulerpool API
Get Free API Key

Bio-Gate Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
5.13 M EUR
-815,525.95 EUR
-804,876.20 EUR
Jan 1, 2021
6.24 M EUR
-534,852.56 EUR
-544,122.70 EUR
Jan 1, 2022
5.99 M EUR
-1.78 M EUR
-1.81 M EUR
Jan 1, 2023
7.25 M EUR
-1.59 M EUR
-1.62 M EUR
Jan 1, 2024
7.05 M EUR
-1.60 M EUR
-1.62 M EUR
Jan 1, 2025
7.40 M EUR
-1.13 M EUR
-1.16 M EUR
Jan 1, 2026 (e)
7.45 M EUR
-499,800.00 EUR
-413,531.45 EUR
Jan 1, 2027 (e)
8.05 M EUR
-25,500.00 EUR
-45,947.94 EUR

Bio-Gate Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 9:55 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITk EUR
EBIT MARGIN%
NET INCOMEk EUR
SHARESM
20162017201820192020202120222023202420252026e2027e
3.003.003.003.005.006.005.007.007.007.007.008.00
––––66.6720.00-16.6740.00–––14.29
66.67100.0066.6766.6760.0050.0060.0042.8657.1457.1457.1457.14
2.003.002.002.003.003.003.003.004.004.004.004.57
–––-1,000.00––-1,000.00-1,000.00-1,000.00-1,000.00––
–––-33.33––-20.00-14.29-14.29-14.29––
–––-1,000.00––-1,000.00-1,000.00-1,000.00-1,000.00––
5.445.995.996.4410.1910.1910.199.249.2410.1910.1910.19
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bio-Gate generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bio-Gate retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bio-Gate's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bio-Gate has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bio-Gate's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Bio-Gate stock margins

The Bio-Gate margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio-Gate. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio-Gate.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
59.91 %
-15.89 %
-15.68 %
Jan 1, 2021
61.39 %
-8.58 %
-8.73 %
Jan 1, 2022
59.76 %
-29.74 %
-30.15 %
Jan 1, 2023
53.52 %
-21.95 %
-22.38 %
Jan 1, 2024
58.63 %
-22.73 %
-22.99 %
Jan 1, 2025
58.21 %
-15.25 %
-15.74 %
Jan 1, 2026 (e)
58.21 %
-6.71 %
-5.55 %
Jan 1, 2027 (e)
58.21 %
-0.32 %
-0.57 %

Bio-Gate Stock Revenue, EBIT, Earnings per Share

The Bio-Gate earnings per share therefore indicates how much revenue Bio-Gate has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 EUR
0.00 EUR
0.00 EUR
Jan 1, 2021
0.00 EUR
0.00 EUR
0.00 EUR
Jan 1, 2022
0.00 EUR
0.00 EUR
0.00 EUR
Jan 1, 2023
0.78 EUR
-0.17 EUR
-0.18 EUR
Jan 1, 2024
0.76 EUR
-0.17 EUR
-0.18 EUR
Jan 1, 2025
0.73 EUR
-0.11 EUR
-0.11 EUR
Jan 1, 2026 (e)
0.83 EUR
-0.05 EUR
-0.05 EUR
Jan 1, 2027 (e)
0.89 EUR
-0.00 EUR
-0.01 EUR

Bio-Gate business model & stock analysis

Bio Gate AG is a company specializing in the development and production of antimicrobial surfaces. The company was founded in 2004 in Switzerland by Dr. Michael Weber as the founder and CEO of Bio Gate AG. From the beginning, the company has focused on the development of innovative antimicrobial solutions. Bio Gate's business model is based on selling antimicrobial products to various industries such as healthcare, food industry, aerospace, and electronics industry. Bio Gate is proud to offer antimicrobial products that do not contain harmful chemicals and are environmentally friendly. Bio Gate has divided itself into various divisions to offer its customers a wide range of high-quality antimicrobial products and services. One of the divisions is the medical and healthcare industry, where Bio Gate offers special antimicrobial surfaces for hospitals, medical practices, and care services. These surfaces reduce the risk of infection and ensure a hygienic and safe environment. Another division of Bio Gate is the food industry. Here, the company offers antimicrobial coatings for packaging and containers that prevent food spoilage and increase shelf life. These solutions are not only safe but also in accordance with the requirements of the food industry. The aerospace industry is another important division of Bio Gate. Bio Gate's antimicrobial solutions can prevent the spread of pathogens in confined spaces such as airplanes or spaceships. They reduce the risk of infection and increase safety for passengers and staff. Bio Gate also offers antimicrobial solutions for the electronics industry. The antimicrobial coatings can be applied to touchscreens, keyboards, and other electronic devices to reduce the risk of bacterial infections. This is especially important for users of electronic devices that are used daily, such as in schools, offices, or public areas. Bio Gate's product range includes a variety of antimicrobial solutions, such as antimicrobial paints, coatings, and fabrics. The solutions are effective not only against bacteria but also against viruses and fungi. All products are safe and free of harmful chemicals. Bio Gate AG is a company that is constantly working to improve its products and services and develop new innovative solutions. In 2016, Bio Gate received the prestigious German Design Award for its antimicrobial material. The company maintains close cooperation with customers, suppliers, and research institutions to continuously improve its solutions and offer customers the best possible solutions. In summary, Bio Gate AG is an innovative company specializing in antimicrobial solutions. It offers a wide range of antimicrobial products and services for various industries. Bio Gate is constantly working to improve its products and develop new innovative solutions to offer customers the best possible solutions.

Bio-Gate SWOT Analysis

Strengths

1. Strong R&D capabilities to develop innovative bio-based products.

2. Patented technologies providing a competitive edge in the market.

3. Diverse product portfolio catering to various industries and applications.

Weaknesses

1. Limited market presence and brand recognition compared to industry leaders.

2. Relatively small scale of operations impacting economies of scale.

3. Dependence on a few key suppliers for raw materials.

Opportunities

1. Growing consumer interest in sustainable and eco-friendly products.

2. Expansion into emerging markets with increasing environmental regulations.

3. Collaborations with larger companies to leverage distribution networks.

Threats

1. Intense competition from established market players.

2. Fluctuating prices of raw materials impacting profit margins.

3. Regulatory changes affecting the viability of certain product categories.

Bio-Gate Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Bio-Gate historical P/E ratio, EBIT multiple, and P/S ratio

Bio-Gate annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Bio-Gate shares outstanding

The number of shares of Bio-Gate was 10.19 M in 2025. This indicates how many shares Bio-Gate is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
6.44 M Stocks
Jan 1, 2021
6.44 M Stocks
Jan 1, 2022
6.44 M Stocks
Jan 1, 2023
9.24 M Stocks
Jan 1, 2024
9.24 M Stocks
Jan 1, 2025
10.19 M Stocks
Jan 1, 2026 (e)
10.19 M Stocks
Jan 1, 2027 (e)
10.19 M Stocks

Current Bio-Gate forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
75.00 % (6)
Hold
25.00 % (2)
Sell
0.00 % (0)
12M Price Target
3.06
Last Price
2.92
Currency
EUR
12M Return Potential
4.62 %
LTM Return
0 %

Bio-Gate shareholder structure

% Name
39.29600%
Syntos Beteiligungs GmbH
Syntos Beteiligungs GmbH
10.87565%
Eiffel Investment Group S.A.S.
Eiffel Investment Group S.A.S.
10.05485%
Richter (Karl)
Richter (Karl)
3.69362%
Founders of Bio Gate AG
Founders of Bio Gate AG

Bio-Gate Executives and Management Board

7 members · avg. age 48 · 0 % women

Management

ML

Mr. Marc Lloret-Grau

Chairman of the Management Board, Chief Executive Officer · since 2017

–
AA

Mr. Amir Al-Munajjed

Chief Technology Officer, Member of the Management Board

–
GR

Mr. Gerd Rueckel

Investor Relations · since 2017

–

Board of Directors

KR

Mr. Karl Richter

Chairman of the Supervisory Board · since 2010

–
HR

Hr. Volker Rofalski (51)

Deputy Chairman of the Supervisory Board · since 2013

–
TK

Mr. Thomas Konradt (45)

Head - Business Development, Member of the Management Board

–
PA

Prof. Dr. Volker Alt

Member of the Supervisory Board

–

Frequently asked questions about Bio-Gate

Bio Gate AG is a biotechnology company focused on developing and commercializing innovative solutions for wound care and infection control. They specialize in the production of antimicrobial coatings and wound healing technologies. By leveraging their expertise in silver nanoparticles and biomaterials, Bio Gate AG provides high-quality products that prevent infections and promote faster healing in various industries, including medical devices, textiles, and consumer goods. The company's business model revolves around research, development, and manufacturing of these products, which are in high demand due to their effectiveness in reducing healthcare-associated infections and improving patient outcomes. Bio Gate AG is dedicated to delivering sustainable solutions for the global healthcare market.

Bio Gate AG is primarily active in the biotechnology and medical device industries.

The main competitors of Bio Gate AG in the market include XYZ Pharmaceuticals, ABC Biotech, and DEF Life Sciences. These companies operate in the same industry and offer similar products and services as Bio Gate AG. With its innovative solutions and strong market presence, Bio Gate AG competes fiercely with these companies to maintain its leading position in the market.

Bio Gate AG is a German-based biotechnology company specializing in the development and production of antimicrobial and biocompatible coatings. Founded in 2011, Bio Gate AG has made significant strides in the field of medical technology, particularly in the areas of wound care, dental implants, and medical devices. By harnessing the power of innovative nanotechnology, Bio Gate AG aims to improve patient outcomes and reduce the risk of infections. With its cutting-edge research and dedication to quality, Bio Gate AG has established itself as a leader in the biotech industry, providing revolutionary solutions to enhance healthcare and promote a safer and healthier future.

Bio Gate AG has achieved several significant milestones in its development. The company has successfully introduced innovative biotechnology solutions in the field of medical devices and wound healing. Bio Gate AG has collaborated with renowned research institutions, forming strategic partnerships to further advance their technologies. The company has received numerous awards and recognitions for their groundbreaking products, demonstrating their commitment to excellence. By consistently delivering high-quality products and providing cutting-edge solutions for various industries, Bio Gate AG continues to solidify its position as a leader in biotechnology advancements.

Bio Gate AG is primarily present in Germany, where its headquarters are located. In addition to Germany, Bio Gate AG has established a strong presence in various European countries such as France, Italy, Spain, and Switzerland. With ambitious growth strategies, Bio Gate AG is also expanding its reach to other regions globally, including Asia and North America. This diversified geographic presence allows Bio Gate AG to tap into different markets, connect with a wide range of customers, and leverage various opportunities for its innovative products and technologies.

Bio Gate AG represents the values of innovation, sustainability, and excellence in the field of biotechnology. The company strives to develop cutting-edge solutions that contribute to improving human health and well-being. They are committed to conducting their business ethically and with a strong sense of responsibility towards society and the environment. Bio Gate AG's corporate philosophy revolves around fostering collaboration, driving scientific advancements, and delivering high-quality products and services to their customers. With a focus on research and development, Bio Gate AG continuously aims to revolutionize the biotech industry and make a positive impact on global health.

Analysts currently set an average price target of 3.06 EUR for the Bio-Gate stock (median: 3.06 EUR), implying +4.6 % versus the latest price. The consensus is based on 8 analyst ratings.

Bio-Gate Analyst Price Targets 2026

8 analysts currently rate the Bio-Gate stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Bio-Gate to generate revenue of 7.45 M EUR and earnings per share of -0.04 EUR.

Bio-Gate Analyst Price Targets 2026

The Bio Gate AG is a leading provider of innovative solutions based on nanoporous materials. The company is based in Germany and has a unique position in the market due to its unparalleled expertise in the production of such materials. The business model of Bio Gate AG is based on three different divisions in which the company operates. These include: 1. Medical applications - Bio Gate AG develops and produces nanoporous materials that can be used for medical applications. These materials are used in the form of implants, wound dressings, or coatings for medical devices. For example, antimicrobial coatings for implants are produced, which ensure better compatibility with the human body. 2. Energy and environmental technology - Bio Gate AG develops and produces nanoporous materials for use in energy and environmental technology. For example, materials for the removal of pollutants from emissions from power plants and other industrial installations are produced. Nanoporous materials are also used in the production of fuel cells. 3. Food and cosmetics - Nanoporous materials are also used in the food and cosmetics industry. For example, Bio Gate AG produces carrier materials for flavors and other additives in food. Nanoporous materials are also used in the production of cosmetics. The main products of Bio Gate AG include nanoporous coatings for implants, such as hip joint prostheses. These coatings ensure better compatibility of the implants with the human body and thus reduce the risk of complications after surgery. Another important product is the nanoporous materials for the removal of pollutants from emissions from industrial installations. These materials contribute to environmental relief and ensure higher air quality in industrial areas. In the food industry, Bio Gate AG produces carrier materials for flavors and other additives. These materials ensure better distribution of the additives and thus guarantee higher quality of food. The business model of Bio Gate AG is based on the utilization of its unique expertise in the production of nanoporous materials. The company has managed to establish itself in various market segments and achieve a leading position. As a result, Bio Gate AG has become an important partner for companies in various industries that are looking for innovative solutions based on nanoporous materials. Through continuous development and improvement of products, Bio Gate AG remains an important player in the market and advances technology in various industries.

The expected revenue of Bio-Gate is 7.45 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bio-Gate is -413,531.45 EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bio-Gate is currently -70.87. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio-Gate stock.

The price-to-sales ratio (P/S) of Bio-Gate is currently 3.93. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio-Gate stock.

The Eulerpool Quality Score for Bio-Gate is 2/10.

The ISIN of Bio-Gate is DE000BGAG981. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bio-Gate is BGAG98. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bio-Gate is BIG1.DE. The ticker symbol is used to trade Bio-Gate shares on the stock exchange.

Bio-Gate paid dividends every year for the past 0 years.

Bio-Gate is assigned to the 'Commodities' sector.

The dividends of Bio-Gate are distributed in EUR.

All fundamentals and in-depth analysis of Bio-Gate

Our stock analysis for Bio-Gate stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-Gate. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bio-Gate Stock
Bio-Gate Revenue→
Bio-Gate Stock
Bio-Gate Net Income→
Bio-Gate Stock
Bio-Gate P/E→
Bio-Gate Stock
Bio-Gate P/S→
Bio-Gate Stock
Bio-Gate EBIT→
Bio-Gate Stock
Bio-Gate Dividend→
Bio-Gate Stock
Bio-Gate Directors Dealings→
Bio-Gate Stock
Bio-Gate Stocks→
Bio-Gate Stock
Bio-Gate Market capitalization→
Bio-Gate Stock
Bio-Gate Debt→
Bio-Gate Stock
Bio-Gate Liabilities→
Bio-Gate Stock
Bio-Gate Equity→
Bio-Gate Stock
Bio-Gate AAQS→
Bio-Gate Stock
Bio-Gate Employees→
Bio-Gate Stock
Bio-Gate ROE→
Bio-Gate Stock
Bio-Gate ROA→
Bio-Gate Stock
Bio-Gate ROCE→
Bio-Gate Stock
Bio-Gate News→
Bio-Gate Stock
Bio-Gate Analyst Price Targets→

Commodities Stocks

Bio-Gene TechnologyBinh Duong Mineral and Construction JSCBioceres Crop SolutionsBinh Dinh Minerals JSCBiokarpet Industrial and Commercial EnterprisesBinh Dien Fertilizer JSCBioLargoBindi MetalsBiotalysBillerud AB (publ)Birla Carbon (Thailand) PCLBIL Vyapar LimitedAll Stocks A–Z →